{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:46:04Z","timestamp":1768319164041,"version":"3.49.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.jocd.2006.01.001","type":"journal-article","created":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T17:11:45Z","timestamp":1149181905000},"page":"47-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Standards for Performing DXA in Individuals With Secondary Causes of Osteoporosis"],"prefix":"10.1016","volume":"9","author":[{"given":"Aliya A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony B.","family":"Hodsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Josse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Kendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Michael","family":"Lewiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech P.","family":"Olszynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Petak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeba A.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Theriault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson B.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2006.01.001_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1385\/JCD:5:4:435","article-title":"Standards and guidelines for performing central dual x-ray densitometry from the Canadian Panel of International Society for Clinical Densitometry","volume":"5","author":"Khan","year":"2002","journal-title":"J Clinic Densitom"},{"key":"10.1016\/j.jocd.2006.01.001_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/JCD:7:1:51","article-title":"Standards and guidelines for performing central dual x-ray densitometry in premenopausal women, men, and children from the Canadian Panel of the International Society of Clinical Densitometry","volume":"7","author":"Khan","year":"2004","journal-title":"J Clin Densitom"},{"issue":"6","key":"10.1016\/j.jocd.2006.01.001_bib3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2006.01.001_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.61.1.32","article-title":"Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice","volume":"61","author":"Gudbjornsson","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jocd.2006.01.001_bib5","first-page":"1298","article-title":"Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort","volume":"28","author":"Mudano","year":"2001","journal-title":"J Rheumatol"},{"issue":"7053","key":"10.1016\/j.jocd.2006.01.001_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jocd.2006.01.001_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"Van Staa","year":"2000","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.jocd.2006.01.001_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.1075","article-title":"The population risk of fractures attributable to oral corticosteroids","volume":"14","author":"Donnan","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.jocd.2006.01.001_bib9","first-page":"435","article-title":"Bone loss after glucocorticoid therapy","volume":"36","author":"LoCascio","year":"1984","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib10","unstructured":"Adachi JD, Bensen WG, Bianchi F, RJ, et al. 1996 Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year follow-up. J Rheumatol 23(6):995\u20131000."},{"issue":"5","key":"10.1016\/j.jocd.2006.01.001_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198308043090502","article-title":"Steroid-induced fractures and bone loss in patients with asthma","volume":"309","author":"Adinoff","year":"1983","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jocd.2006.01.001_bib12","first-page":"804","article-title":"Predictors of fractures in early rheumatoid arthritis","volume":"18","author":"Michel","year":"1991","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jocd.2006.01.001_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780280402","article-title":"Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases","volume":"28","author":"Dykman","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.jocd.2006.01.001_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"Van Staa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.jocd.2006.01.001_bib15","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy","volume":"48","author":"Van Staa","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jocd.2006.01.001_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jocd.2006.01.001_bib17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","article-title":"Children and the risk of fractures caused by oral corticosteroids","volume":"18","author":"Van Staa","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2006.01.001_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00198-003-1398-z","article-title":"Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review","volume":"14","author":"Richy","year":"2003","journal-title":"Osteoporos Int"},{"issue":"12 Pt 1","key":"10.1016\/j.jocd.2006.01.001_bib19","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1164\/rccm.200206-606OC","article-title":"Inhaled corticosteroids and hip fracture: a population-based case-control study","volume":"166","author":"Hubbard","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jocd.2006.01.001_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/ajrccm.170.1.950","article-title":"Inhaled corticosteroids and fracture risk in COPD","volume":"170","author":"Suissa","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jocd.2006.01.001_bib21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1164\/rccm.200307-926OC","article-title":"Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease","volume":"169","author":"Lee","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jocd.2006.01.001_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00198-004-1606-5","article-title":"Are inhaled corticosteroids associated with an increased risk of fracture in children?","volume":"15","author":"Van Staa","year":"2004","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.jocd.2006.01.001_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.1996.00550080071014","article-title":"Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis","volume":"53","author":"Schwid","year":"1996","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.jocd.2006.01.001_bib24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2003.011734","article-title":"Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study","volume":"63","author":"Haugeberg","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jocd.2006.01.001_bib25","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/ard.2004.030908","article-title":"A 2 year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs","volume":"64","author":"Choy","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jocd.2006.01.001_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/ard.62.4.350","article-title":"Oral corticosteroid prescribing in women over 50, use of fracture prevention therapy, and bone densitometry service","volume":"62","author":"Chantler","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jocd.2006.01.001_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jocd.2006.01.001_bib28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Glucocorticoid-Induced Osteoporosis Intervention Study Group. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jocd.2006.01.001_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","article-title":"Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy","volume":"67","author":"Wallach","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/jn\/135.2.332","article-title":"Vitamin D insufficiency in North America","volume":"135","author":"Hanley","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.jocd.2006.01.001_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1359\/jbmr.0301216","article-title":"Vignettes in osteoporosis: a road map to successful therapeutics","volume":"19","author":"Rosen","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2006.01.001_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1034\/j.1399-0012.2003.02065.x","article-title":"Predominant factors associated with bone loss in liver transplant patients after prolonged post-transplantation period","volume":"17","author":"Segal","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jocd.2006.01.001_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1381\/096089204322917792","article-title":"Bone mineral density in females after jejunoileal bypass: a 25-year follow-up study","volume":"14","author":"Vage","year":"2004","journal-title":"Obes Surg"},{"key":"10.1016\/j.jocd.2006.01.001_bib34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/gut.52.5.653","article-title":"Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection","volume":"52","author":"Haderslev","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jocd.2006.01.001_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/003655202753416876","article-title":"Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease","volume":"37","author":"Jahnsen","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jocd.2006.01.001_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1155\/2003\/391308","article-title":"The frequency of vitamin D deficiency in adults with Crohn's disease","volume":"17","author":"Siffledeen","year":"2003","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jocd.2006.01.001_bib37","first-page":"290","article-title":"Post-gastrectomy bone disease undiagnosed for forty years","volume":"112","author":"Ghose","year":"1999","journal-title":"N Z Med J"},{"key":"10.1016\/j.jocd.2006.01.001_bib38","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1164\/ajrccm.157.6.9712089","article-title":"Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease","volume":"157","author":"Donovan","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jocd.2006.01.001_bib39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/gut.38.3.322","article-title":"Reversal of osteopenia with diet in adult coeliac disease","volume":"38","author":"Valdimarsson","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jocd.2006.01.001_bib40","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis","volume":"44","author":"Nieves","year":"1994","journal-title":"Neurology"},{"issue":"230","key":"10.1016\/j.jocd.2006.01.001_bib41","first-page":"569","article-title":"A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy","volume":"59","author":"Gough","year":"1986","journal-title":"Q J Med"},{"key":"10.1016\/j.jocd.2006.01.001_bib42","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/ajcn\/51.6.1075","article-title":"An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston","volume":"51","author":"Webb","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jocd.2006.01.001_bib43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jcem-67-2-373","article-title":"Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin","volume":"67","author":"Webb","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib44","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/0190-9622(90)70107-S","article-title":"Use of topical sunscreen for the evaluation of regional synthesis of vitamin D3","volume":"22","author":"Matsuoka","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jocd.2006.01.001_bib45","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archderm.1995.01690230119023","article-title":"Regular use of sunscreen on vitamin D levels","volume":"131","author":"Holick","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jocd.2006.01.001_bib46","series-title":"Dietary reference intakes for calcium, magnesium, phosphorus, vitamin D, and fluoride","author":"Food and Nutrition Board, Institute of Medicine","year":"1997"},{"key":"10.1016\/j.jocd.2006.01.001_bib47","first-page":"1517","article-title":"Vitamin D insufficiency in a population of healthy western Canadians","volume":"166","author":"Rucker","year":"2002","journal-title":"CMAJ"},{"issue":"Suppl 6","key":"10.1016\/j.jocd.2006.01.001_bib48","doi-asserted-by":"crossref","first-page":"1706S","DOI":"10.1093\/ajcn\/80.6.1706S","article-title":"Functional indices of vitamin D status and ramifications of vitamin D deficiency","volume":"80","author":"Heaney","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jocd.2006.01.001_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s001980050030","article-title":"Prevalence of vitamin D insufficiency in an adult normal population","volume":"7","author":"Chapuy","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1359\/jbmr.1998.13.2.168","article-title":"Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women","volume":"13","author":"Riggs","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2006.01.001_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jcem-58-2-223","article-title":"Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans","volume":"58","author":"Marcus","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/jc.2002-021064","article-title":"Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D","volume":"88","author":"Vieth","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib53","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1210\/jc.2003-031979","article-title":"Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization","volume":"89","author":"Binkley","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib54","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2004-0682","article-title":"Editorial: the determination of circulating 25-hydroxyvitamin D: no easy task","volume":"89","author":"Hollis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s002280050175","article-title":"Diminished effect of etidronate in vitamin D deficient osteopenic postmenopausal women","volume":"51","author":"Koster","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jocd.2006.01.001_bib56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1297-319X(03)00046-0","article-title":"Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency","volume":"70","author":"Grados","year":"2003","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jocd.2006.01.001_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1385\/JCD:5:3:267","article-title":"Dramatic improvement of BMD following vitamin D therapy in a bone marrow transplant recipient","volume":"5","author":"Arekat","year":"2002","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2006.01.001_bib58","first-page":"2729","article-title":"Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density","volume":"84","author":"Adams","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib59","series-title":"Stedman's Medical Dictionary","year":"1995"},{"key":"10.1016\/j.jocd.2006.01.001_bib60","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4158\/EP.8.6.439","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients\u20142002 update","volume":"8","author":"Petak","year":"2002","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jocd.2006.01.001_bib61","article-title":"Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis","volume":"11","author":"Seftel","year":"2005","journal-title":"Int J Impot Res Aug 11"},{"key":"10.1016\/j.jocd.2006.01.001_bib62","first-page":"S184","article-title":"Alendronate treatment of Osteoporosis in Men","volume":"14","author":"Orwoll","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2006.01.001_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2006.01.001_bib64","first-page":"1966","article-title":"Effect of testosterone treatment on bone mineral density in men over 65 years of age","volume":"84","author":"Snyder","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2006.01.001_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.159.2.139","article-title":"Bone mineral density in women using dept medroxyprogesterone acetate for contraception","volume":"159","author":"Scholes","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jocd.2006.01.001_bib66","first-page":"898","article-title":"The effects of estrogen administration of trabecular bone loss in young women with anorexia nervosa","volume":"80","author":"Klibanski","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jocd.2006.01.001_bib67","first-page":"1344","article-title":"Perspectives on the Women's Health Initiative trial of hormone replacement therapy","volume":"100","author":"Grimes","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jocd.2006.01.001_bib68","unstructured":"U.S. Preventive Services Task Force of the U.S. Dept of Health's Agency for Healthcare Research and Quality. September 2002 guidelines. Available at: http:\/\/www.ahrg.gov\/clinic\/uspstf\/uspsoste.htm. Accessed December 20, 2005."},{"key":"10.1016\/j.jocd.2006.01.001_bib69","unstructured":"National Osteoporosis Foundation. NOF guidelines for bone density testing. Available at: http:\/\/www.nof.org\/osteoporosis\/bonemass.htm. Accessed December 20, 2005."},{"issue":"6","key":"10.1016\/j.jocd.2006.01.001_bib70","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4158\/EP.9.6.544","article-title":"for the AACE Osteoporosis Task Force. 2003 American Association of Clinical Endocrinologists medical guidelines for clinical practice and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003","volume":"9","author":"Hodgson","year":"2004","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jocd.2006.01.001_bib71","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1210\/jc.2004-0124","article-title":"International Society for Clinical Densitometry. Official positions of the international society for clinical densitometry","volume":"89","author":"Lewiecki","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4158\/EP.6.5.385","article-title":"Skeletal effects of primary hyperparathyroidism","volume":"6","author":"Khan","year":"2000","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jocd.2006.01.001_bib73","doi-asserted-by":"crossref","unstructured":"Silverberg SJ, Shane E, Jacobs TP, et al. 1999 A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery [erratum in N Engl J Med 2000;342:144] N Engl J Med 241:1249\u20131255.","DOI":"10.1056\/NEJM199910213411701"},{"key":"10.1016\/j.jocd.2006.01.001_bib74","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"Suppl","key":"10.1016\/j.jocd.2006.01.001_bib75","first-page":"S166","article-title":"Three-dimensional assessment of trabecular architecture in mild primary hyperparathyroidism","volume":"17","author":"Dempster","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.jocd.2006.01.001_bib76","first-page":"N2","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"17","author":"Bilezikian","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.jocd.2006.01.001_bib77","first-page":"N98","article-title":"Bone densitometry in asymptomatic primary hyperparathyroidism","volume":"17","author":"Miller","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2006.01.001_bib78","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4158\/EP.9.5.400","article-title":"Position paper: asymptomatic primary hyperparathyroidism - standards and guidelines for diagnosis and management in Canada","volume":"9","author":"Khan","year":"2003","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.jocd.2006.01.001_bib79","first-page":"1901","article-title":"Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism","volume":"85","author":"Nakoaka","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib80","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism: a randomized controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"issue":"14","key":"10.1016\/j.jocd.2006.01.001_bib81","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/archinte.160.14.2161","article-title":"Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women","volume":"160","author":"Orr-Walker","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jocd.2006.01.001_bib82","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib83","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib84","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"90","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib85","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jocd.2006.01.001_bib86","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"Brit Med J"},{"key":"10.1016\/j.jocd.2006.01.001_bib87","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int"},{"issue":"Suppl 3","key":"10.1016\/j.jocd.2006.01.001_bib88","first-page":"S1","article-title":"K\/DOQI Clinical Guidelines for bone metabolism and disease in chronic renal disease","volume":"42","author":"Massry","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jocd.2006.01.001_bib89","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.1990.187","article-title":"Renal bone disease: an unmet challenge for the nephrologist","volume":"38","author":"Malluche","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib90","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertension"},{"key":"10.1016\/j.jocd.2006.01.001_bib91","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.semnephrol.2003.08.012","article-title":"Bone disease after transplantation","volume":"24","author":"Sprague","year":"2004","journal-title":"Seminars in Nephrology"},{"key":"10.1016\/j.jocd.2006.01.001_bib92","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1359\/jbmr.040912","article-title":"Management of bone loss after organ transplantation","volume":"19","author":"Cohen","year":"2004","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.jocd.2006.01.001_bib93","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"370","article-title":"Transplantation osteoporosis","author":"Cohen","year":"2003"},{"issue":"Suppl 3","key":"10.1016\/j.jocd.2006.01.001_bib94","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1177\/089686080102103S44","article-title":"Fragility fractures in dialysis and transplant patients. Is it osteoporosis, and how should it be treated?","volume":"21","author":"Hodsman","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib95","first-page":"57","article-title":"Fractures and vertebral bone mineral density in patients with renal osteodystrophy","volume":"30","author":"Piraino","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jocd.2006.01.001_bib96","first-page":"1","article-title":"Bone densitometry: patients with end-stage renal disease","volume":"8","author":"Erlichman","year":"1996","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jocd.2006.01.001_bib97","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/ndt\/14.5.1238","article-title":"The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis","volume":"14","author":"Matuszkiewicz-Rowinska","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jocd.2006.01.001_bib98","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/ndt\/14.8.1922","article-title":"Risk factors for reduced bone density in haemodialysis patients","volume":"14","author":"Taal","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jocd.2006.01.001_bib99","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S8756-3282(96)00246-3","article-title":"Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures","volume":"19","author":"Yamaguchi","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2006.01.001_bib100","first-page":"115","article-title":"Osteoporosis in end-stage renal disease","volume":"19","author":"Lindberg","year":"1999","journal-title":"Seminars in Nephrology"},{"key":"10.1016\/j.jocd.2006.01.001_bib101","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2003.12.004","article-title":"Osteoporosis in chronic kidney disease","volume":"43","author":"Cunningham","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jocd.2006.01.001_bib102","first-page":"218","article-title":"Fracture and bone mineral density in hemodialysis patients","volume":"54","author":"Fontaine","year":"2000","journal-title":"Clinical Nephrology"},{"key":"10.1016\/j.jocd.2006.01.001_bib103","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000168600","article-title":"Bone mineral density in patients with end-stage renal failure","volume":"13","author":"Gabay","year":"1993","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jocd.2006.01.001_bib104","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1523-1755.2000.00170.x","article-title":"Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women","volume":"58","author":"Weisinger","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2006.01.001_bib106","first-page":"101","article-title":"No important influence of limited steroid exposure on bone mass during the first year after renal transplant: a prospective, randomized, multicenter study","volume":"78","author":"ter Meulen","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jocd.2006.01.001_bib107","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/00007890-199410270-00009","article-title":"Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients","volume":"58","author":"Grotz","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.jocd.2006.01.001_bib108","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk factors","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2006.01.001_bib109","first-page":"S1","article-title":"2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.jocd.2006.01.001_bib110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8529(02)00024-5","article-title":"Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fracture risk","volume":"31","author":"Guyatt","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jocd.2006.01.001_bib111","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1046\/j.1523-1755.2003.00005.x","article-title":"Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis","volume":"63","author":"Hernandez","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib112","first-page":"684","article-title":"Pamidronate therapy as prevention of bone loss following renal transplantation","volume":"7","author":"Fan","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib113","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1046\/j.1523-1755.2003.00012.x","article-title":"Long-term effects on bone mineral density of pamidronate given at the time of transplantation","volume":"63","author":"Fan","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib114","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","article-title":"Prevention of bone loss in renal transplant recepients: A prospective, randomized trial of intravenous pamidronate","volume":"14","author":"Coco","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jocd.2006.01.001_bib115","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1681\/ASN.V1271530","article-title":"Effect of ibandronate on bone loss and renal function after kidney tansplantation","volume":"12","author":"Grotz","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jocd.2006.01.001_bib116","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1523-1755.2003.00816.x","article-title":"Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation","volume":"63","author":"Haas","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocd.2006.01.001_bib117","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0041-1345(02)02872-5","article-title":"Alendronate increases bone mineral density in long-term renal transplant recipients","volume":"34","author":"Koc","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jocd.2006.01.001_bib118","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1359\/jbmr.2001.16.11.2111","article-title":"Alendronate prevents further bone loss in renal transplant recipients","volume":"16","author":"Giannini","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2006.01.001_bib119","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/01.TP.0000092523.30277.13","article-title":"Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate","volume":"76","author":"Jeffery","year":"2003","journal-title":"Transplant"},{"key":"10.1016\/j.jocd.2006.01.001_bib120","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1523-1755.2004.00369.x","article-title":"Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation","volume":"65","author":"Schwarz","year":"2004","journal-title":"Kidney Int"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695006000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695006000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:32:43Z","timestamp":1761082363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695006000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1094695006000205"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2006.01.001","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standards for Performing DXA in Individuals With Secondary Causes of Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2006.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}